StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AGI.BO$599.45+1.70%
Fair $599.45+0.0%

AGI.BO

AGI Greenpac Limited

Consumer Cyclical / Packaging & ContainersBSE

$599.45

+10.00 (+1.70%)

Fairly Valued+0.0%Fair Value $599.45Fund rank 36/100 · Data gapFallback financials|
SA 51/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.7B · quality 76.0/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 75/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · AGI.BOLocal privado en este navegador · AGI Greenpac Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$38.8B

P/E

10.8x

↓

EV/EBITDA

5.9x

↓

ROE

14.6%

↑

Gross Margin

70.9%

↑

Debt/Equity

0.10

↓
52-Week Range$599
$444$1008

TradingView lightweight chart

AGI.BO price, volumen y niveles de valoración

Último $599.45Periodo +27418.4%
Fair value: $599.45

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+5.7%

FCF CAGR

-10.2%

FCF margin

6.6%

FCF / Net income

0.50x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $26.65B · net income $3.52B · FCF $1.75B

2023-FY → 2026-FY

Gross margin

70.9%+15.1% pts

Operating margin

15.9%-0.5% pts

Net margin

13.2%+1.6% pts

FCF margin

6.6%-4.1% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$26.65B$26.65B$25.29B$24.00B$22.56B
Net Income$3.52B$3.52B$3.22B$2.51B$2.62B
EBITDA$6.85B$6.85B$6.89B$5.88B$4.88B
EPS——49.8338.8540.44
Gross Margin70.9%70.9%70.2%59.0%55.8%
Operating Margin15.9%15.9%17.3%16.6%16.4%
Net Margin13.2%13.2%12.7%10.5%11.6%
Balance Sheet
Debt/Equity0.100.100.260.340.46
Current Ratio1.511.51———
Cash Flow
Free Cash Flow$1.75B$1.75B$1.75B$3.16B$2.42B
Returns
ROE14.6%14.6%15.4%13.9%16.3%
Valuation
P/E10.8510.8515.3521.918.97
EV/EBITDA5.905.907.9510.025.85
P/B1.611.612.363.031.46
Growth & Yield
Revenue Growth5.4%5.4%5.4%6.4%—
EPS Growth——28.3%-3.9%—
Dividend Yield1.2%1.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -29.3%

Total return

-29.3%

Start / end P/E

n/dx → n/dx

EPS bridge

49.83 → n/d

Residual

-30.5%

EPS growthn/d
Multiple reratingn/d
Dividend+1.2%
Residual / FX / buybacks / cross-term-30.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.